The Organization for Economic Cooperation and Development is asking member governments to harmonize and streamline clinical trial approval processes, OECD Global Science Forum project administrator Frederic Sgard writes. Complex and inconsistent regulations lead to delays and higher costs, and can prevent trials from going forward, he writes.

Related Summaries